# Haitao Jin > Haitao Jin is a Series B investor at Shenzhen Capital Group backing Solar and Energy. See 2 investments, check sizes, portfolio. Updated Aug 2026. - Type: Angel Investor - Fund: [Shenzhen Capital Group](https://shizune.co/investors/profile/shenzhen-capital-group) - Total investments: 2 - Last investment: Jun 2022 - Lead investor: 50% - Last updated: Aug 2026 - LinkedIn: https://www.linkedin.com/in/haitao-jin-306aa032 Haitao Jin is a Series B investor at Shenzhen Capital Group focused on Solar and Energy. Chairman JIN has 30 years of business management, investment, financial, and capital market operations experience, including receiving advanced training at investment banking house Morgan Stanley in New York. He is the President of the Shenzhen Venture Capital Association, President of the Beijing Municipal Association of Private Equity, VicePresident of the Shenzhen City Chamber of Commerce and Investment, and Honorary President of the Wenzhou City (Zhejiang Province) Capital Association. Chairman JIN previously served as the Vice-President of the Shenzhen SEG Group, and President of subsidiary listed company Shenzhen SEG Co. Ltd., (ticker: 000058.SZ). He directly managed five listed companies and issued A-Shares six times in the China equity capital markets. Chairman JIN joined Shenzhen Capital Group as Chairman in 2004. ## Investment focus ### Industry | Industry | Investments | Share | | --- | --- | --- | | Solar | 1 | 50% | | Energy | 1 | 50% | | Medical | 1 | 50% | | Health Care | 1 | 50% | | Clean Energy | 1 | 50% | 7 industries tracked in total. ### Stage | Stage | Investments | Share | | --- | --- | --- | | Series B | 1 | 50% | | Series E | 1 | 50% | ## Investments | Company | Description | Amount | Stage | Date | Website | | --- | --- | --- | --- | --- | --- | | Renogy | Renogy provide people with reliable and affordable access to nature’s cleanest energy resource. | | Series E | Jun 07, 2022 | | | Ascletis | Ascletis is a joint venture between U.S. and Chinese entrepreneurs aimed at building a global specialty therapeutics business dedicated to discovering and developing important new treatments for cancer and infectious diseases. Ascletis leverages U.S./European innovation and pharmaceutical/biotech strategic experience and China'scapital efficiency with a goal of establishing in the near term a sustainable business and accelerated revenues through the in-licensing, late-stage clinical development, and commercialization of new medicines for the growing Chinese pharmaceutical marketplace. At the same time, the company is building long-term value through the discovery, demonstration of clinical proof-of-concept, and global partnering of novel therapeutics for life-threatening diseases. | $100M | Series B | Jan 03, 2017 | | 2 of 2 investments shown. ## Co-investors - [C-Bridge Capital](https://shizune.co/investors/profile/cbridge-capital) — VC Fund, 1 deal together - [Focus Media](https://shizune.co/investors/profile/focus-media-2) — VC Fund, 1 deal together ## About Shenzhen Capital Group VC Fund · Shenzhen, China Shenzhen Capital Group Co., Ltd (“SCGC”) is a limited venture capital company established by the Shenzhen Government in 1999. Since its establishment, SCGC has focused on cultivating national industries, shaping national brands, promoting economic transformation, and emerging industries developing. SCGC has registered capital of 5.42 billion RMB,and a total AUM of 338.99 billion RMB. SCGC primarily invests in SMEs, innovative high-tech enterprises, enterprises in emerging industries, and enterprises in start-up period, growth period and in transformation, covering industries supported by national policies, including IT, internet, new media, biopharma, new energy, environmental protection, chemical engineering, new material, high-end equipment manufacturing, consumption goods, modern service, etc. By the end of April 2019, SCGC ranked the first based on the number of portfolio companies and the number of listed portfolio companies: 994 portfolio companies, investments totaling 43.9 billion RMB, 145 of which have been listed in 16 capital markets worldwide. 5 contacts available at Shenzhen Capital Group. | Name | Title | Profile | | --- | --- | --- | | Bo Sheng | General Manager of Nantong city fund | https://shizune.co/investors/profile/bo-sheng | | Dongsheng Sun | Group Vice President | https://shizune.co/investors/profile/dongsheng-sun | | Gang Liu | General Manager of Beijing city fund | https://shizune.co/investors/profile/gang-liu | | Haitao Jin | Chairman | https://shizune.co/investors/profile/haitao-jin | | Hanxin Zhong | Head of Audit & Supervision | https://shizune.co/investors/profile/hanxin-zhong | ## Similar investors ### Similar stage - [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund - [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund - [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund ## FAQ ### What does Haitao Jin invest in? Haitao Jin invests primarily in Solar, Energy and Medical startups, most often at Series B and Series E stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio. ### When did Haitao Jin last invest? The most recent investment recorded for Haitao Jin closed in Jun 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly. ### Is Shizune's investor data accurate? Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page. # About Shizune Shizune.co is an investor database. Core features: - 48,091 startup investors (angels, VCs, accelerators, and others) - Email, phone, LinkedIn (for intros), socials, and other contact data - Updated daily from public funding news - CSV and Excel export The User can access the full database FOR FREE after signing up: shizune.co